Phase 1/2 Trial of Medigene’s MDG1011 Immunotherapy in Blood Cancer Patients Set to Begin
A Phase 1/2 clinical trial testing an experimental T-cell…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
New Test Speeds Time to Determine Success of Bone Marrow Transplants
Scientists have developed a new test that shortens the…
Myeloma Patients, Advocates Trek to Mt. Everest’s Doorstep to Raise Awareness
To raise awareness of multiple myeloma and funding for…
Mouse Study Finds Potential Targets to Minimize Risks of Stem Cell Transplants
Immune factors that drive donor T-cells to cause…
Xgeva Use in Myeloma May Be Expanded to Europe Following Positive CHMP Opinion
Treatment of bone lesions in multiple myeloma patients with…
Revlimid Combo Treatment Improved Survival in Newly-diagnosed Myeloma Patients in Phase 3 Trial
Newly diagnosed multiple myeloma patients unable to undergo…
